Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ECULIZUMAB for Haemolytic uraemic syndrome: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 8,500 adverse event reports in the FDA FAERS database where ECULIZUMAB was used for Haemolytic uraemic syndrome.

Most Reported Side Effects for ECULIZUMAB

Side Effect Reports % Deaths Hosp.
Fatigue 4,858 11.0% 91 944
Off label use 4,228 9.6% 577 658
Haemoglobin decreased 3,028 6.9% 127 1,045
Headache 2,699 6.1% 56 700
Death 2,221 5.0% 2,221 540
Pyrexia 1,948 4.4% 128 1,129
Dyspnoea 1,819 4.1% 97 737
Asthenia 1,732 3.9% 95 627
Drug ineffective 1,644 3.7% 164 472
Nausea 1,579 3.6% 47 516
Malaise 1,562 3.5% 91 591
Platelet count decreased 1,502 3.4% 111 659
Haemolysis 1,476 3.3% 87 557
Hospitalisation 1,345 3.0% 75 1,336
Blood lactate dehydrogenase increased 1,290 2.9% 79 420

Other Indications for ECULIZUMAB

Paroxysmal nocturnal haemoglobinuria (12,054) Product used for unknown indication (6,808) Atypical haemolytic uraemic syndrome (5,848) Myasthenia gravis (5,715) Off label use (3,550) Thrombotic microangiopathy (1,312) Neuromyelitis optica spectrum disorder (1,097) C3 glomerulopathy (267) Transplant rejection (176) Antiphospholipid syndrome (126)

Other Drugs Used for Haemolytic uraemic syndrome

SOLIRIS (811) RAVULIZUMAB-CWVZ (93) PREDNISONE (16) UNSPECIFIED INGREDIENT (7) RITUXIMAB (6) METHYLPREDNISOLONE (5)

Related Pages

ECULIZUMAB Full Profile All Haemolytic uraemic syndrome Drugs ECULIZUMAB Demographics ECULIZUMAB Timeline